Search Results - "Belter, Lisa"

Refine Results
  1. 1

    Quality of life data for individuals affected by spinal muscular atrophy: a baseline dataset from the Cure SMA Community Update Survey by Belter, Lisa, Cruz, Rosángel, Jarecki, Jill

    Published in Orphanet journal of rare diseases (24-08-2020)
    “…Individuals and/or caregivers of individuals affected by spinal muscular atrophy (SMA) completed the 2019 Cure SMA Community Update Survey, online, assessing…”
    Get full text
    Journal Article
  2. 2

    Knowledge of genetic test results among caregivers and individuals with spinal muscular atrophy by Belter, Lisa, Mazzella, Allison, O'Brien, Shannon, Jarecki, Jill

    Published in PloS one (08-11-2022)
    “…Spinal muscular atrophy (SMA) is a progressive recessive genetic disease. Early identification is critical for achieving maximal treatment benefit. Survival…”
    Get full text
    Journal Article
  3. 3

    Telemedicine Use, Comfort, and Perceived Effectiveness in the Spinal Muscular Atrophy Community by Peterson, Ilse S, Belter, Lisa T, Curry, Mary A, Jarecki, Jill

    Published in Telemedicine journal and e-health (01-02-2024)
    “…Telemedicine may increase access to clinical care, particularly for mobility-limited communities such as the spinal muscular atrophy (SMA) community. However,…”
    Get more information
    Journal Article
  4. 4

    "I have SMA, SMA doesn't have me": a qualitative snapshot into the challenges, successes, and quality of life of adolescents and young adults with SMA by Mazzella, Allison, Curry, Mary, Belter, Lisa, Cruz, Rosángel, Jarecki, Jill

    Published in Orphanet journal of rare diseases (22-02-2021)
    “…With the approval of three treatments for spinal muscular atrophy (SMA) and several promising therapies on the horizon, the SMA adolescent and young adult…”
    Get full text
    Journal Article
  5. 5

    Evaluating Perceived Fatigue within an Adult Spinal Muscular Atrophy Population by Belter, Lisa, Peterson, Ilse, Jarecki, Jill

    Published in Neurology and therapy (01-12-2023)
    “…Introduction Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by progressive muscle weakness and atrophy. While…”
    Get full text
    Journal Article
  6. 6

    Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA) by Curry, Mary, Cruz, Rosángel, Belter, Lisa, Schroth, Mary, Lenz, Megan, Jarecki, Jill

    Published in BMC pediatrics (17-05-2021)
    “…Spinal Muscular Atrophy (SMA), a leading genetic cause of death in infants, is an autosomal recessive neuromuscular disease characterized by progressive muscle…”
    Get full text
    Journal Article
  7. 7

    The availability, functionality, and quality of mobile applications supporting medication self-management by Bailey, Stacy Cooper, Belter, Lisa T, Pandit, Anjali U, Carpenter, Delesha M, Carlos, Eamon, Wolf, Michael S

    “…To systematically review mobile applications currently available to patients to support outpatient medication self-management. Three online stores were…”
    Get full text
    Journal Article
  8. 8

    Assessment of Barriers to Referral and Appointment Wait Times for the Evaluation of Spinal Muscular Atrophy (SMA): Findings from a Web-Based Physician Survey by Curry, Mary A., Cruz, Rosángel E., Belter, Lisa T., Schroth, Mary K., Jarecki, Jill

    Published in Neurology and therapy (01-06-2024)
    “…Background Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by progressive muscle weakness and atrophy. Clinical…”
    Get full text
    Journal Article
  9. 9

    Effects of the COVID-19 Pandemic on SMA Screening and Care: Physician and Community Insights by Curry, Mary, Peterson, Ilse, Belter, Lisa, Sarr, Fatou, Whitmire, Sarah, Schroth, Mary, Jarecki, Jill

    Published in Neurology and therapy (01-10-2023)
    “…Objective As part of efforts to reduce diagnostic delays and enhance clinical trials, Cure SMA evaluated the effects of COVID-19 on SMA care and clinical trial…”
    Get full text
    Journal Article
  10. 10

    Assessing the impact of grief on quality of life, work productivity, and health outcomes for parents bereaved from SMA: A study protocol by Riley, Abigail G, Mulé, Christina M, Lerner, Debra, Belter, Lisa, O'Toole, Colleen McCarthy, Kowal, Stacey, Fox, David, Shapouri, Sheila, Vesel, Tamara, Lavelle, Tara A

    Published in Cost effectiveness and resource allocation (23-08-2023)
    “…Background U.S. cost-effectiveness recommendations suggest that analyses should include all costs and effects relevant to the decision problem [1]. However, in…”
    Get full text
    Journal Article
  11. 11

    Older Adult Preferences of Mobile Application Functionality Supporting Medication Self-Management by Russell, Andrea M., Smith, Samuel G., Bailey, Stacy C., Belter, Lisa T., Pandit, Anjali U., Hedlund, Laurie A., Bojarski, Elizabeth A., Rush, Steven R., Wolf, Michael S.

    Published in Journal of health communication (02-12-2018)
    “…Health systems and insurers alike are increasingly interested in leveraging mHealth (mobile health) tools to support patient health-related behaviors including…”
    Get full text
    Journal Article
  12. 12

    Economic burden of spinal muscular atrophy: an analysis of claims data by Belter, Lisa, Cruz, Rosángel, Kulas, Sierra, McGinnis, Emily, Dabbous, Omar, Jarecki, Jill

    “…Background: Spinal muscular atrophy (SMA) is a rare genetic neuromuscular disease. Objective: Characterize direct costs associated with SMA management. Data…”
    Get full text
    Journal Article
  13. 13

    The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices by Peterson, Ilse S., Mazzella, Allison J., Belter, Lisa T., Curry, Mary A., Cruz, Rosángel E., Jarecki, Jill

    Published in Neurology and therapy (01-09-2022)
    “…Introduction Understanding clinical trial experiences can illuminate opportunities to optimize trial design and management, with potential benefits for…”
    Get full text
    Journal Article
  14. 14

    An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA members by Belter, Lisa, Cook, Suzanne F, Crawford, Thomas O, Jarecki, Jill, Jones, Cynthia C, Kissel, John T, Schroth, Mary, Hobby, Kenneth

    Published in Journal of neuromuscular diseases (2018)
    “…The Cure SMA database is one of the largest patient reported databases for people affected with SMA. The purpose of this study was to examine a subset of…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20